Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2701–2750 of 75356
On April 17, 2025, Mr. Fraser notified the Windtree Therapeutics, Inc.(the “ Company ”) Board of Directors (the “ Board ”) of his resignation from the Board, effective immediately.
On April 18, 2025, Vera Bradley, Inc. (the “Company”) announced that long-time board member Frances P. Philip will not stand for re-election at the upcoming 2025 Shareholder Meeting.
Mr. Machan no longer serves as the Company’s Interim Chief Financial Officer effective April 14, 2025
On April 18, 2025, Michael C. Greiner announced that he will leave Avanos Medical, Inc. (the “Company”) to pursue other opportunities because the Company did not offer him a position comparable to the one he held prior to his role as the Company’s Interim Chief Executive Officer.
On April 15, 2025,Dexter Fowler and Jennifer Prince notified the Board of Directors (the “Board”) of System1, Inc. (the “Company”) of their respective resignation from the Board, effective as of the close of business on April 15, 2025.
On April 15, 2025,Dexter Fowler and Jennifer Prince notified the Board of Directors (the “Board”) of System1, Inc. (the “Company”) of their respective resignation from the Board, effective as of the close of business on April 15, 2025.
On April 15, 2025, Messrs. William C. Mulligan and Edward K. Zinser announced their intention to not stand for re-election at the 2026 Annual Meeting.
On April 15, 2025, Messrs. William C. Mulligan and Edward K. Zinser announced their intention to not stand for re-election at the 2026 Annual Meeting.
Jay Malave, its Chief Financial Officer, advised the Company of his intention to pursue other opportunities outside of the Company.
On April 16, 2025, Kyle Crockett, Vice President, Controller and Chief Accounting Officer of Carrier Global Corporation (the “Company”), informed the Company that he is resigning to pursue another opportunity.
his resignation from the AGM Board will be effective as of April 21, 2025.
On April 16, 2025, Richard Parisi and Elizabeth LaPuma delivered notice to the board of directors (the “Board”) of ContextLogic Inc. (the “Company”) of their resignation as directors, effective immediately, to pursue other opportunities.
On April 16, 2025, Richard Parisi and Elizabeth LaPuma delivered notice to the board of directors (the “Board”) of ContextLogic Inc. (the “Company”) of their resignation as directors, effective immediately, to pursue other opportunities.
On April 14, 2025, Carl L. Gordon, Ph.D., a Class II member of the board of directors (the “Board”) of Adicet Bio, Inc. (the “Company”), notified the Company of his resignation from the Board and Compensation Committee of the Board (the “Compensation Committee”), effective on April 17, 2025.
On April 11, 2025, D. Gary Gilliland, M.D., Ph.D., a member of the board of directors (the “Board”) of Nuvalent, Inc. (the “Company”), notified the Company of his decision to resign from the Board and from all committees of the Board on which he serves, effective as of the date and time of the Company’s 2025 annual meeting of stockholders.
On April 11, 2025, Timothy Haley informed the Company of his decision to not stand for re-election as a director at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”).
Current director Jennifer Banner will not stand for re-election at, and her current term as a director will end, at the Annual Meeting.
On April 14, 2025, Gary P. Fayard, currently a director on the Board of Directors (the “Board”) of Monster Beverage Corporation (the “Company”), provided notice to the Board and management of the Company of his intention not to stand for reelection at the 2025 Annual Meeting of the Stockholders (the “2025 Annual Meeting”).
On April 16, 2025, J. Drayton Wise notified Insmed Incorporated (the “Company”) of his decision to resign from his position as the Company’s Chief Commercial Officer for personal and medical reasons, effective immediately.
Effective April 15, 2025, Frank Galea resigned as Chief Compliance Officer of PennantPark Floating Rate Capital Ltd. (the “Company”).
Effective April 15, 2025, Frank Galea resigned as Chief Compliance Officer of PennantPark Investment Corporation (the “Company”).
In addition, on April 16, 2025, in connection with the Agreement, Franklin Berger informed the Board that he would retire following the end of his current term as a Class I director at the 2027 Annual Meeting.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
On April 15, 2025, Charles Watts, M.D., a member of the Board of Directors (the “Board”) of Biodesix, Inc. (the “Company”), notified the Company of his intention to resign from his position as a director of the Board and as a member of the Compensation Committee, effective at the conclusion of the Company’s 2025 Annual Meeting of Stockholders on May 20, 2025.
Christopher R. Delaney, a named executive officer in the 2025 proxy statement, left his employment with The Goodyear Tire & Rubber Company (the “Company”) effective on April 14, 2025.
On April 12, 2025, Lynn Liang notified the Board of Directors (the “Board”) of Health In Tech, Inc., a Nevada corporation (the “Company”) that she is resigning from the Board effective April 18, 2025.
On April 17, 2025, Waterstone Financial, Inc. (the “Company”), announced today that Michael Hansen has decided to retire as a Director of the Company and its wholly-owned subsidiary WaterStone Bank SSB.
On April 2, 2025, the majority shareholder of the THC Therapeutics, Inc. (the "Company"), voted to remove Brandon Romanek from the Board of Directors of the Company. Further, on that same day, the remaining Board of Directors removed Mr. Romanek from any and all positions held at the Company.
Mr. Corrales assumed a new role within Southern Peru Copper Corporation, Sucursal del Perú as the Advising Director of New Projects effective April 10, 2025.
Todd L. Capitani, the Company’s current Chief Financial Officer, who previously announced his retirement, will continue with the Company until August 15, 2025 to support this leadership transition.
On April 16, 2025, Sweetgreen, Inc. (the “Company”) and Rossann Williams, the Company’s Chief Operating Officer, mutually agreed that Ms. Williams would leave her employment with the Company, effective immediately.
The disclosures set forth in Item 1.01 regarding Norman E. Snyder’s retirement and resignation from the positions of Chief Executive Officer and director and the terms of the Transition Agreement are incorporated into this section (b) by this reference.
On April 11, 2025, Kevin Mohan resigned as Chief Investment Officer of Sadot Group Inc. (the “Company”), effective May 5, 2025.
On April 16, 2025, the Company and Ajay Kataria, the Company’s Executive Vice President, Chief Financial Officer and Principal Accounting Officer, mutually determined that, effective as of May 1, 2025, (the “CFO Effective Date”), Mr. Kataria would no longer serve in his roles as the Company’s Executive Vice President, Chief Financial Officer and Principal Accounting Officer
Effective on April 17, 2025, Gregory Mays, Chief Operating Officer of the Company, stepped down from his role as Chief Operating Officer, but will stay on as an employee of the Company for a mutually agreed timeframe, in order to assist with the transition of his duties and responsibilities.
On April 16, 2025, Dave Davis, President, Chief Financial Officer and member of the board of directors (the “Board”) of Sun Country Airlines Holdings, Inc. (the “Company”), informed the Board that he would be stepping down from his position with the Company and as a member of the Board, effective immediately.
On April 16, 2025, Liselotte Hyveled informed the Board of Directors (the “Board”) of TriSalus Life Sciences, Inc. (the “Company”) of her decision to resign from her position as a member of the Board, the Nominating and Corporate Governance Committee of the Board and the Science and Technology Committee of the Board, effective immediately.
Mr. Arigo’s employment with the Company terminated by mutual agreement without cause.
Mr. Morris plans to retire on July 18, 2025.
Effective on April 15, 2025, Mr. Frank Galea, the Chief Compliance Officer of 5C Lending Partners Corp. (the “Company”), has resigned from his position at the Company.
On April 14, 2025, the Company and Mr. Bauer entered into a general release and separation agreement (the “Separation Agreement”).
On April 10, 2025, Bertrand Loy informed the Company that he will not stand for re-election at the Company’s 2025 Annual Meeting.
On April 11, 2025, Shane Crehan notified Zoom Communications, Inc. (the “Company”) of his decision to resign from his role as the Company’s Chief Accounting Officer and principal accounting officer, effective as of May 2, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.